Pharmacelera is a research oriented company and SME preferred H2020 partner. Looking for a Small and Medium Enterprise consisting of a professional, experienced and trusting team for your consortium? If so, let us know at info [at] pharmacelera.com! We have expertise in different areas that may complement your skills: high performance computing, drug discovery, computational chemistry, hardware acceleration, big data, machine learning...
Pharmacelera has established collaborations with the following institutions:
The Computational Biology & Drug Design Group (CBDD) from the University of Barcelona is Pharmacelera's key partner in the research and development of novel and more accurate software models for computer-aided drug design.
The CBDD group has an extensive publication record in computational biology and drug discovery that complements Pharmacelera's expertise. This collaboration has led so far to the development of new molecular descriptors that are integrated in Pharmacelera's products like PharmScreen and PharmQSAR and are published in several scientific publications.
Pharmacelera collaborates with RISC Software GmbH developing high performance tools within the PRACE program. RISC Software GmbH is an austrian company that performs research and development for industrial partners. The core competences symbolic computation, mathematics and computer science are applied to develop remarkable software solutions in logistics informatics, applied scientific computation, medical informatics and advanced computing technologies.
Pharmacelera has been collaborating with the Barcelona Supercomputing Center finding better ways to execute protein-ligand dynamics. Pharmacelera provides its expertise in hardware acceleration in order to enable faster simulations. As an example of this collaboration, we have been able to reduce the execution time of a molecular solvent from 84 seconds to 4 seconds by using a hardware accelerator (an AMD Graphics Processing Unit - GPU).
Pharmacelera is also member of the Mont-Blanc project end-user group and has been able to work with the ARM-based cluster prototypes for scientific software acceleration with promising results.
Bayncore and Pharmacelera also collaborate finding new ways of accelerating software taking advantage of Intel processors capabilities for High Performance Computing.
CIMA (Centro de Investigación Médica Aplicada) brings pure research closer to its clinical application, and collaborates with the pharmaceutical and biotechnological industry to develop products for diagnosis and treatment. The main purpose of the center is to carry out high-quality scientific work, combating diseases that cause great suffering and for which no cure has yet been discovered. The interdisciplinary work carried out by physicians, biologists, biochemists, pharmacists, engineers, laboratory technicians and other professionals is organized into four priority research divisions: Gene Therapy and Hepatology, Cardiovascular Sciences, Neurosciences and Oncology.
Pharmacelera's PharmScreen has been tested with two sets of scaffolds from CIMA in order to perform a virtual screening of Phosphodiesterase-5 inhibitors and Melanin concentrating hormone 1-receptors. Results have shown that PharmScreen has been able to detect a significantly higher number of hits than similar software from the competition.
Pharmacelera is a member of the Pistoia Alliance, a global, not-for-profit alliance of life science companies, vendors, publishers, and academic groups that work together to lower barriers to innovation in R&D. The Pistoia Alliance is a group of life sciences industry experts that uses pre-competitive collaboration to address issues around aggregating, accessing, and sharing data that are essential to innovation, but provide little competitive advantage.
Pharmacelera is a member of the Bioinformatics Barcelona Association (BIB). BIB is a non-profit association for the provision of education and training, the promotion of advanced research, knowledge and technology transfer, the stimulation of competitiveness and innovation within the industrial sector, and the provision of greater visibility as an international node in the field of Bioinformatics.
Pharmacelera is a member of the Industrial Advisory Committee (IAC) of PRACE. PRACE is established as an international not-for-profit association (aisbl) with seat in Brussels. It has 25 member countries whose representative organizations create a pan-European supercomputing infrastructure, providing access to computing and data management resources and services for large-scale scientific and engineering applications at the highest performance level.